Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Turki Al Fayea"'
Autor:
Abdul Rahman Jazieh, Adda Bounedjar, Fouad Al Dayel, Shamayel Fahem, Arafat Tfayli, Kakil Rasul, Hassan Jaafar, Mohammad Jaloudi, Turki Al Fayea, Hatim Q Al Maghrabi, Hanaa Bamefleh, Khaled Al Kattan, Blaha Larbaoui, Taha Filali, Hamed Al Husaini, Yosra Ali, in collaboration with the Arab Collaborative Hematology Oncology Group (ACHOG)
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 4-7 (2019)
Background: Druggable molecular targets are very important in the management of non-small-cell lung cancer (NSCLC). The purpose of our study is to determine the pattern of testing and mutation prevalence in the Middle East and North Africa population
Externí odkaz:
https://doaj.org/article/4c952f09ea8e4a439f3761fca3a7b712
Autor:
AR Jazieh on Behalf of Saudi Lung Cancer Guidelines Association - Saudi Lung Cancer Guidelines Members, Abdul Rahman Jazieh, Khaled Al Kattan, Ahmed Bamousa, Ashwaq Al Olayan, Ahmed Abdelwarith, Jawaher Ansari, Abdullah Al Twairqi, Turki Al Fayea, Khalid Al Saleh, Hamed Al Husaini, Nafisa Abdelhafiez, Mervat Mahrous, Medhat Faris, Ameen Al Omair, Adnan Hebshi, Salem Al Shehri, Foad Al Dayel, Hanaa Bamefleh, Walid Khalbuss, Sarah Al Ghanem, Shukri Loutfi, Azzam Khankan, Meshael Al Rujaib, Majed Al Ghamdi, Nagwa Ibrahim, Abdulmonem Swied, Mohammad Al Kayait, Marie Datario
Publikováno v:
Annals of Thoracic Medicine, Vol 12, Iss 4, Pp 221-246 (2017)
Background: Lung cancer management is getting more complex due to the rapid advances in all aspects of diagnostic and therapeutic options. Developing guidelines is critical to help practitioners provide standard of care. Methods: The Saudi Lung Cance
Externí odkaz:
https://doaj.org/article/e8594a6a4fef4da98db83ae6dca46ab7
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 1, Pp 411-417 (2021)
Case Reports in Oncology, Vol 14, Iss 1, Pp 411-417 (2021)
Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) of the gallbladder are rare with no established therapeutic strategies. We report a case of recurrent gallbladder MiNEN from a population with a low incidence of gallbladder carcinomas, a revi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b90ad3b35ec492b1feac7d1f2590f478
http://europepmc.org/articles/PMC7983664
http://europepmc.org/articles/PMC7983664
Autor:
Hatim Q Al Maghrabi, Turki Al Fayea, Arafat Tfayli, Fouad Al Dayel, Hamed Al Husaini, Hanaa Bamefleh, Blaha Larbaoui, Kakil Ibrahim Rasul, Hassan Jaafar, Yosra Z. Ali, Khaled Al Kattan, Abdul Rahman Jazieh, Mohammad Jaloudi, Adda Bounedjar, Shamayel Fahem, Taha Filali
Publikováno v:
Journal of Immunotherapy and Precision Oncology. 2:4-7
Background: Druggable molecular targets are very important in the management of non-small-cell lung cancer (NSCLC). The purpose of our study is to determine the pattern of testing and mutation prevalence in the Middle East and North Africa population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::542eb06cd626bdc7473d207bde762146
https://doi.org/10.4103/jipo.jipo_22_18
https://doi.org/10.4103/jipo.jipo_22_18
Autor:
Shamayel Fahem, Hanaa Bamefleh, Arafat Tfayli, Hatim Q. Almaghrabi, Hamed Alhusaini, Kakil Ibrahim Rasul, Foad Al Dayel, Turki Al Fayea, Adda Bounedjar, Abdul Rahman Jazieh, Mohammad Jaloudi, Taha Filalli, Hassan Jaafar, Blaha Larbaoui, Mufid Al Mistiri, Khaled Alkattan
Publikováno v:
Journal of thoracic disease. 11(12)
Background: Accurate pathological diagnosis is the first critical step in the management of lung cancer. This step is important to determine the histological subtype of the cancer and to identify any actionable targets. Our study aimed at evaluating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebbf913cb1f51c38eb10edc820878162
https://pubmed.ncbi.nlm.nih.gov/32030233
https://pubmed.ncbi.nlm.nih.gov/32030233
Autor:
AbdulRahman Jazieh, null AR Jazieh, Khaled Al Kattan, Ahmed Bamousa, Ashwaq Al Olayan, Ahmed Abdelwarith, Jawaher Ansari, Abdullah Al Twairqi, Turki Al Fayea, Khalid Al Saleh, Hamed Al Husaini, Nafisa Abdelhafiez, Mervat Mahrous, Medhat Faris, Ameen Al Omair, Adnan Hebshi, Salem Al Shehri, Foad Al Dayel, Hanaa Bamefleh, Walid Khalbuss, Sarah Al Ghanem, Shukri Loutfi, Azzam Khankan, Meshael Al Rujaib, Majed Al Ghamdi, Nagwa Ibrahim, Abdulmonem Swied, Mohammad Al Kayait, Marie Datario
Publikováno v:
Annals of Thoracic Medicine, Vol 12, Iss 4, Pp 221-246 (2017)
Annals of Thoracic Medicine
Annals of Thoracic Medicine
Background: Lung cancer management is getting more complex due to the rapid advances in all aspects of diagnostic and therapeutic options. Developing guidelines is critical to help practitioners provide standard of care. Methods: The Saudi Lung Cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ba2ea0cfc6c4b2f9b0892291d1e2eee
http://www.thoracicmedicine.org/article.asp?issn=1817-1737
http://www.thoracicmedicine.org/article.asp?issn=1817-1737
Publikováno v:
Drug Safety. 32:1109-1122
Cisplatin is one of the most widely used antineoplastic agents in the treatment of solid tumour and haematological malignancies, including cancers of the testes, ovary, bladder, head and neck, oesophagus, stomach and lung, as well as lymphoma and ost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ab2b370ed25e19d12483165779a0b37
https://doi.org/10.2165/11316640-000000000-00000
https://doi.org/10.2165/11316640-000000000-00000
Publikováno v:
Journal of Thoracic Oncology. 3:1272-1278
Introduction Adjuvant chemotherapy in non-small cell lung cancer (NSCLC) has become a new standard of care. This study examines the uptake patterns for adjuvant chemotherapy outside of clinical trials. Methods A retrospective study of all patients di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86cb8a7a3428b32166eac27a5d257991
https://doi.org/10.1097/jto.0b013e318189f562
https://doi.org/10.1097/jto.0b013e318189f562
Autor:
Turki Al-Fayea, Tallal Younis, Wojciech Morzycki, Kiran Virik, Daniel Rayson, Nathalie Saint-Jacques
Publikováno v:
Journal of Thoracic Oncology. 3(8):865-870
Introduction Wait times in cancer care continue to be an important clinical, social, and political issue. This study examines wait times along the care path from suspicious imaging study (Detection) to adjuvant chemotherapy initiation (Chemotherapy)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a45536a7e8abef6fd25eb24df18d0583
Autor:
Jamal Zekri, Turki Al Fayea, Tarek Darwish, Mohamed Mokhtar Ibrahim, Maged Mansour, Meteb Owaish Al-Foheidi, Mervat Mahrous, Azhar Rizvi
Publikováno v:
Journal of Clinical Oncology. 32:e11543-e11543
e11543 Background: Lapatinib (L) in combination with capecitabine (C) is approved for patients withadvanced/metastatic Her2+ breast cancer (A/MHer2+BC) after progression on Trastuzumab (T) based th...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f50536a2ae79917978a8fe5eaefc37f
https://doi.org/10.1200/jco.2014.32.15_suppl.e11543
https://doi.org/10.1200/jco.2014.32.15_suppl.e11543